GlassScriptPhysician profile
Walter J Doty
NPI 1932151719
$1,942.71
in general payments reported to CMS, 2019-2025
27 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $263 · 2021: $158 · 2022: $649 · 2023: $413 · 2024: $196 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $682.72 | 2020-2025 | Trelegy Ellipta, Boostrix, Shingrix |
| Electromed, INC. | $216.22 | 2021-2025 | Smartvest |
| Allergan, INC. | $177.51 | 2019-2020 | |
| Abbvie INC. | $165.97 | 2019-2023 | Synthroid, Ubrelvy |
| Novo Nordisk INC | $119.77 | 2022 | |
| Abbott Laboratories | $110.45 | 2022-2023 | Freestyle Libre 3 |
| Pfizer INC. | $50.94 | 2022-2023 | |
| Gilead Sciences, INC. | $45.68 | 2021-2022 | |
| Corcept Therapeutics | $40.65 | 2020-2021 | |
| Ascendis Pharma Endocrinology INC | $29.91 | 2023 | |
| Ethicon INC. | $26.09 | 2023 | Monarch Platform |
| Welch Allyn | $25.79 | 2021 | |
| Baxter Healthcare | $25.79 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.02 | 2019 | |
| Amarin Pharma, INC. | $24.64 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $19.98 | 2023 | |
| Tactile Systems Technology INC | $18.69 | 2022 | |
| Insmed, INC. | $18.33 | 2020 | |
| Merck Sharp & Dohme LLC | $17.25 | 2019 | |
| Intuitive Surgical, INC. | $16.99 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.91 | 2023 | Trulance, Xifaxan |
| Harmony Biosciences LLC | $15.31 | 2020 | |
| Lilly USA, LLC | $14.33 | 2020 | |
| Medtronic Minimed, INC. | $12.71 | 2020 | |
| Melinta Therapeutics, LLC | $11.95 | 2022 | |
| Janssen Pharmaceuticals, INC | $10.79 | 2019 | |
| Veran Medical Technologies, INC. | $3.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.